Pharma companies race to develop mental health treatments

Pharmaceutical companies now target depression, bipolar disorder and schizophrenia as priority investment areas.

Published 13sem2 sources✓ ConfirmedNotableupdated 6sem

≈ 17sSpeed

The fact

This shift responds to growing demand for psychiatric disorder treatments.

Mental health has become a major strategic market for pharmaceutical groups.

2 sources — click a link to read an article on the topic:

Explore this topic

Jun 21Pharma companies race to develop mental health treatmentsthis article

Auto-synthesis from 2 media sources · identified on June 21, 2026